CIK 0000921299
- Non-accelerated filer
- Smaller reporting company
KYNTRA BIO, INC.
Sign in to watch- Ticker
- KYNB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 770357827
- Phone
- +1 415-978-1200
- Business address
- 350 BAY STREET, SUITE 100 #6009, SAN FRANCISCO, CA, 94133
- Former names
- FIBROGEN INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-24 | Chung Christine SVP, China Operations | Grant or award · Stock Option (Right to Buy) | +41,700 | 41,700 | ||
| 2021-02-24 | Conterno Enrique A Chief Executive Officer | Grant or award | +82,000 | 137,273 | ||
| 2021-02-24 | Conterno Enrique A Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +164,000 | 164,000 | ||
| 2021-02-17 | Kurkijarvi Kalevi Director | Exercise or conversion | +6,000 | $28.65 | $172K | 39,100 |
| 2021-02-17 | Kurkijarvi Kalevi Director | Sale | −5,156 | $52.31 | $270K | 33,944 |
| 2021-02-17 | Kurkijarvi Kalevi Director | Sale | −844 | $52.93 | $45K | 33,100 |
| 2021-02-17 | Kurkijarvi Kalevi Director | Exercise or conversion · Stock Option (Right to Buy) | −6,000 | 6,000 | ||
| 2021-01-19 | Kurkijarvi Kalevi Director | Exercise or conversion | +6,000 | $19.05 | $114K | 39,100 |
| 2021-01-19 | Kurkijarvi Kalevi Director | Sale | −6,000 | $43.38 | $260K | 33,100 |
| 2021-01-19 | Kurkijarvi Kalevi Director | Exercise or conversion · Stock Option (Right to Buy) | −6,000 | 0 | ||
| 2021-01-14 | Kurkijarvi Kalevi Director | Exercise or conversion | +5,999 | $19.05 | $114K | 39,099 |
| 2021-01-14 | Kurkijarvi Kalevi Director | Sale | −5,999 | $40.04 | $240K | 33,100 |
| 2021-01-14 | Kurkijarvi Kalevi Director | Exercise or conversion · Stock Option (Right to Buy) | −5,999 | 6,000 | ||
| 2021-01-06 | Conterno Enrique A Chief Executive Officer | Shares withheld for taxes | −5,411 | $38.31 | $207K | 55,273 |
| 2021-01-04 | Schoeneck James A Director | Exercise or conversion | +6,000 | $9.78 | $59K | 15,400 |
| 2021-01-04 | Schoeneck James A Director | Exercise or conversion · Stock Option (Right to Buy) | −6,000 | 0 | ||
| 2020-12-28 | Kurkijarvi Kalevi Director | Exercise or conversion | +6,000 | $18.34 | $110K | 39,100 |
| 2020-12-28 | Kurkijarvi Kalevi Director | Exercise or conversion | +1 | $19.05 | $19 | 39,101 |
| 2020-12-28 | Kurkijarvi Kalevi Director | Sale | −5,901 | $40.39 | $238K | 33,200 |
| 2020-12-28 | Kurkijarvi Kalevi Director | Sale | −100 | $41.14 | $4K | 33,100 |
Page 17 of 33 · 651 trades